NPI: 1932132313 · NASHVILLE, TN 37211 · 261QE0700X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 7,479 | $236K |
| 2019 | 7,390 | $295K |
| 2020 | 7,418 | $284K |
| 2021 | 5,450 | $195K |
| 2022 | 2,745 | $166K |
| 2023 | 1,937 | $162K |
| 2024 | 1,877 | $104K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | 21,444 | 1,899 | $1.29M | |
| J0887 | Epoetin beta esrd use | 968 | 491 | $120K |
| J0882 | Darbepoetin alfa, esrd use | 803 | 221 | $34K |
| J0604 | Cinacalcet, esrd on dialysis | 1,281 | 125 | $2K |
| A4657 | Syringe w/wo needle | 5,949 | 827 | $0.00 |
| 82728 | 819 | 726 | $0.00 | |
| J2501 | Paricalcitol | 447 | 50 | $0.00 |
| 86580 | 21 | 19 | $0.00 | |
| 82306 | 46 | 35 | $0.00 | |
| J1270 | Injection, doxercalciferol | 84 | 12 | $0.00 |
| 83540 | 817 | 726 | $0.00 | |
| 84100 | 148 | 92 | $0.00 | |
| 82310 | 128 | 80 | $0.00 | |
| 84466 | 817 | 726 | $0.00 | |
| 83970 | 390 | 331 | $0.00 | |
| J1756 | Iron sucrose injection | 134 | 36 | $0.00 |